APONTIS PHARMA AG (DE:APPH)
XETRA:APPH
Germany Market
Advertisement

APONTIS PHARMA AG (APPH) Ratios

Compare
6 Followers

APONTIS PHARMA AG Ratios

DE:APPH's free cash flow for Q2 2025 was €0.28. For the 2025 fiscal year, DE:APPH's free cash flow was decreased by € and operating cash flow was €0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
6.82 3.21 7.19 12.53 0.74
Quick Ratio
4.30 2.69 6.66 11.03 0.58
Cash Ratio
3.69 2.41 6.10 9.72 0.44
Solvency Ratio
0.20 -0.35 0.25 0.07 0.02
Operating Cash Flow Ratio
-0.34 -1.13 1.85 1.12 0.08
Short-Term Operating Cash Flow Coverage
0.00 -2.09 0.00 0.00 0.00
Net Current Asset Value
€ 8.64M€ 8.43M€ 24.57M€ 25.04M€ -12.75M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.10 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.20 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.17 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.39 1.90 1.44 1.33 8.59
Debt Service Coverage Ratio
69.68 -1.54 94.42 2.47 1.54
Interest Coverage Ratio
-0.05 -212.68 118.11 4.12 -0.70
Debt to Market Cap
0.00 0.15 0.00 0.00 0.00
Interest Debt Per Share
<0.01 0.72 <0.01 0.05 0.10
Net Debt to EBITDA
-3.90 1.61 -6.41 -14.96 -7.71
Profitability Margins
Gross Profit Margin
25.27%62.68%62.79%66.01%63.77%
EBIT Margin
2.17%-39.97%6.96%1.28%-1.55%
EBITDA Margin
5.63%-35.01%10.18%3.90%2.66%
Operating Profit Margin
>-0.01%-40.85%10.17%3.27%-1.55%
Pretax Profit Margin
2.10%-40.16%6.87%0.49%-3.77%
Net Profit Margin
1.26%-30.58%4.82%-1.46%-3.01%
Continuous Operations Profit Margin
1.26%-30.58%4.82%-1.46%-3.01%
Net Income Per EBT
60.22%76.14%70.24%-300.18%80.07%
EBT Per EBIT
-62361.33%98.32%67.52%14.85%242.43%
Return on Assets (ROA)
1.49%-19.67%4.49%-1.38%-3.98%
Return on Equity (ROE)
2.09%-37.35%6.47%-1.83%-34.21%
Return on Capital Employed (ROCE)
>-0.01%-32.58%10.52%3.27%-5.36%
Return on Invested Capital (ROIC)
>-0.01%-21.74%7.39%-9.83%-4.29%
Return on Tangible Assets
2.63%-28.31%6.15%-1.89%-7.92%
Earnings Yield
0.72%-27.99%3.86%-0.44%-0.74%
Efficiency Ratios
Receivables Turnover
27.80 27.57 23.70 17.51 29.85
Payables Turnover
13.80 2.71 3.87 5.79 4.36
Inventory Turnover
4.98 2.39 6.55 3.78 4.86
Fixed Asset Turnover
4.50K 1.22K 1.25K 2.74K 954.20
Asset Turnover
1.18 0.64 0.93 0.95 1.32
Working Capital Turnover Ratio
2.83 1.20 1.54 3.35 -10.05
Cash Conversion Cycle
60.00 31.41 -23.23 54.32 3.58
Days of Sales Outstanding
13.13 13.24 15.40 20.85 12.23
Days of Inventory Outstanding
73.31 152.86 55.70 96.46 75.04
Days of Payables Outstanding
26.44 134.69 94.34 62.99 83.69
Operating Cycle
86.44 166.10 71.11 117.31 87.27
Cash Flow Ratios
Operating Cash Flow Per Share
-0.12 -1.48 1.30 0.40 0.17
Free Cash Flow Per Share
-0.13 -1.87 0.91 0.21 0.08
CapEx Per Share
<0.01 0.38 0.39 0.20 0.09
Free Cash Flow to Operating Cash Flow
1.01 1.26 0.70 0.52 0.50
Dividend Paid and CapEx Coverage Ratio
-145.37 -3.86 3.36 2.07 1.99
Capital Expenditure Coverage Ratio
-145.37 -3.86 3.36 2.07 1.99
Operating Cash Flow Coverage Ratio
0.00 -2.09 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
-0.02 -0.34 0.20 0.07 0.04
Free Cash Flow Yield
-1.15%-39.28%11.11%1.04%0.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
138.72 -3.57 25.92 -228.12 -134.73
Price-to-Sales (P/S) Ratio
1.75 1.09 1.25 3.32 4.06
Price-to-Book (P/B) Ratio
2.87 1.33 1.68 4.18 46.09
Price-to-Free Cash Flow (P/FCF) Ratio
-86.96 -2.55 9.00 95.86 220.91
Price-to-Operating Cash Flow Ratio
-87.55 -3.20 6.33 49.51 109.84
Price-to-Earnings Growth (PEG) Ratio
-10.55 <0.01 -0.06 6.11 2.69
Price-to-Fair Value
2.87 1.33 1.68 4.18 46.09
Enterprise Value Multiple
27.26 -1.51 5.88 70.27 144.82
Enterprise Value
79.42M 19.58M 33.35M 140.16M 151.32M
EV to EBITDA
27.26 -1.51 5.88 70.27 144.82
EV to Sales
1.53 0.53 0.60 2.74 3.86
EV to Free Cash Flow
-76.06 -1.23 4.31 79.03 209.74
EV to Operating Cash Flow
-76.58 -1.55 3.03 40.82 104.28
Tangible Book Value Per Share
1.51 1.50 2.99 3.06 -1.33
Shareholders’ Equity Per Share
3.80 3.56 4.89 4.79 0.41
Tax and Other Ratios
Effective Tax Rate
0.40 0.24 0.30 4.00 0.20
Revenue Per Share
6.22 4.35 6.56 6.02 4.62
Net Income Per Share
0.08 -1.33 0.32 -0.09 -0.14
Tax Burden
0.60 0.76 0.70 -3.00 0.80
Interest Burden
0.97 1.00 0.99 0.38 2.42
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-1.58 1.11 4.10 -4.61 -1.23
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis